Recombinant coronavirus-like particle COVID-19 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant coronavirus-like particle COVID-19 vaccine, covering 2022-04-06 to 2022-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults [Phase 2, Phase 3]